Skip to main content

Table 4 Bedside principles for optimizing antibiotic prescribing in the ICU

From: Antibiotic stewardship in the ICU: time to shift into overdrive

Carry out a thorough clinical examination with oriented imaging ± whole-body CT scan

Use invasive diagnostic tools, especially if the patient is severe on admission. Microbiological sampling is mandatory prior administering antibiotic

If septic shock is suspected, use broad-spectrum combination therapy within one hour

Without shock, if a potential source of infection is identified, use monotherapy unless specific recommendation (e.g., community-acquired pneumonia)

Without shock, if sepsis is suspected and no source of infection identified, withhold antimicrobial treatment. Search for differential diagnosis

Empiric antibiotic therapy should be selected based on identified source and local ecology

Limit the use of carbapenems to patients with a high likelihood of ESBL infection. Use of rectal or respiratory ESBL colonization may be useful

Systematically reassess antibiotic therapy after 48 h

De-escalation should be done as early as possible. For early de-escalation, ESBL-chromogenic tests may be useful

In the absence of documentation after 48 h, search for a differential diagnosis

In most cases, the definitive treatment should be a monotherapy. Combination therapy can be discussed for difficult-to-treat pathogens or specific localizations (endocarditis, prosthetic device infection, joint and bone infection, abscess)

Use prolonged beta-lactam infusion after initial loading dose in severe patients (e.g., shock)

TDM is recommended for aminoglycosides and vancomycin, and in general for antibiotics having narrow therapeutic window or suspected drug toxicity

Beta-lactams TDM should be used for prolonged therapy and in specific situations (augmented renal clearance, renal replacement therapy, ECMO)

Use short-course (7-day) for most of infections. PCT may be useful to help shorten the duration of antimicrobial treatment

  1. CT computed-tomography, ECMO extracorporeal membrane oxygenation, ESBL extended-spectrum-beta-lactamase, ICU intensive care unit, PCT procalcitonin, TDM therapeutic drug monitoring